Fennec Pharmaceuticals Inc. (FENC) Earnings History
Net Loss26 years of earnings data (2000–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Fennec Pharmaceuticals Inc. (FENC) Earnings Overview
As of June 29, 2026, Fennec Pharmaceuticals Inc. (FENC) reported trailing twelve-month net income of -$8M, reflecting -2150.0% year-over-year growth. The company earned $-0.24 per diluted share over the past four quarters, with a net profit margin of -21.8%.
Looking at the long-term picture, FENC's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2011.
Fennec Pharmaceuticals Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LCTX (-$64M net income, -436.5% margin), SNOA (-$3M net income, -16.3% margin), HALO ($349M net income, 22.7% margin), FENC has outperformed on profitability metrics. Compare FENC vs LCTX →
FENC Earnings vs Peers
Earnings metrics vs comparable public companies
FENC Historical Earnings Data (2000–2025)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | -2134.2% | -$6M | $-0.36 | -21.8% | -14.2% |
| 2024 | $-436,000 | +97.3% | $2M | $-0.02 | -0.9% | 5.2% |
| 2023 | -$16M | +32.3% | -$13M | $-0.60 | -75.5% | -61.4% |
| 2022 | -$24M | -36.7% | -$23M | $-0.95 | -1544.9% | -1481.3% |
| 2021 | -$17M | +4.2% | -$17M | $-0.67 | - | - |
| 2020 | -$18M | -38.5% | -$18M | $-0.76 | -10652.4% | -10520.6% |
| 2019 | -$13M | -32.2% | -$13M | $-0.63 | - | - |
| 2018 | -$10M | -40.3% | -$10M | $-0.52 | - | - |
| 2017 | -$7M | -152.6% | -$7M | $-0.47 | - | - |
| 2016 | -$3M | -323.2% | -$3M | $-0.22 | - | - |
| 2015 | $-659,000 | +69.7% | -$2M | $-0.06 | - | - |
| 2014 | -$2M | -217.9% | -$3M | $-0.22 | - | - |
| 2013 | $2M | +135.7% | -$2M | $0.17 | - | - |
| 2012 | -$5M | -210.2% | -$4M | $-0.62 | - | - |
| 2011 | $5M | +159.9% | -$3M | $0.58 | - | - |
| 2010 | -$8M | -159.7% | -$5M | $-1.11 | - | - |
| 2009 | -$3M | +77.9% | -$3M | $-0.98 | - | - |
| 2008 | -$14M | -1.8% | -$14M | $-4.43 | - | - |
| 2007 | -$13M | +30.1% | -$14M | $-4.78 | - | - |
| 2006 | -$19M | +0.7% | -$19M | $-16.72 | - | - |
| 2005 | -$19M | -120.3% | -$18M | $-12.99 | - | - |
| 2004 | -$9M | -42.1% | -$9M | $-15.04 | - | - |
| 2003 | -$6M | -65.3% | -$7M | $-19.85 | - | - |
| 2002 | -$4M | -51.5% | -$4M | $-3.86 | - | - |
| 2001 | -$2M | +0.0% | -$3M | $-4.04 | -245465800.0% | -264882700.0% |
| 2000 | -$2M | - | -$3M | $-2.98 | - | - |
Download Data
Export FENC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FENC — Frequently Asked Questions
Quick answers to the most common questions about buying FENC stock.
What is FENC earnings per share (EPS)?
FENC trailing twelve-month (TTM) diluted EPS is $-0.24, reflecting -2150.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2000 to 2025 is available in the table on this page.
What is Fennec Pharmaceuticals Inc.'s net income?
Fennec Pharmaceuticals Inc. (FENC) trailing twelve-month net income is $-8M as of 2025. Earnings declined -2150.0% year-over-year.
Is FENC profitable?
FENC is not currently profitable on a TTM basis, reporting a net loss of $-8M. Net margin is -21.8%. Investors should monitor for a return to profitability.
What is FENC's earnings growth rate?
FENC compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2000 to 2025.
What are FENC's profit margins?
Fennec Pharmaceuticals Inc. net profit margin is -21.8%, operating margin is -14.2%, and gross margin is +91.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is -66.8%.
Is FENC growing earnings?
FENC earnings are declining — EPS fell -2150.0% year-over-year. TTM net income dropped to $-8M. This contrasts with the 5-year CAGR of N/A.
What was FENC's best earnings year?
Fennec Pharmaceuticals Inc.'s highest annual net income on record is $5M, achieved in fiscal year 2011. Earnings history on this page spans 2000 to 2025 and includes all annual and quarterly figures.
What were FENC's earnings last quarter?
FENC's most recent reported quarter was Q1 2026. Net income was $201000.00 with diluted EPS of $0.01. For a full breakdown of all quarters, see the quarterly earnings table on this page.